Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

SARS-COV-2

  • Open Access
    Response to Letter to the Editor from Finsterer: “Encephalitis Associated With SARS-CoV-2 Infection in a Child With Chiari Malformation Type I”
    JOSÉ MANUEL REYES-RUIZ, FERNANDO BASTIDA-GONZÁLEZ and ROSA MARÍA DEL ÁNGEL
    In Vivo November 2023, 37 (6) 2859-2862; DOI: https://doi.org/10.21873/invivo.13403
  • Open Access
    The Burden of COVID-19 in Adult Patients With Hematological Malignancies: A Single-center Experience After the Implementation of Mass-vaccination Programs Against SARS-CoV-2
    VASILIKI RAPTI, AMALIA PAPANIKOLOPOULOU, GEORGIOS KOKKOTIS, MARIA-EFFROSYNI LIVANOU, POLYXENI ALEXIOU, EVMORFIA PECHLIVANIDOU, NIKOLAOS K. SYRIGOS, NIKOLAOS SPERNOVASILIS, ANDRIANI CHARPIDOU and GARYFALLIA POULAKOU
    In Vivo November 2023, 37 (6) 2743-2754; DOI: https://doi.org/10.21873/invivo.13385
  • Open Access
    A Prospective Study of AFree Oral Spray as an Adjuvant Therapy for Mild and Moderate COVID-19 in Community Health Stations: Clinical Progression and Viral Clearance Outcomes
    DUONG T. TRAN, TRUONG N. PHAM, NHUNG HT NGUYEN, HAU D. TRAN, HUY Q. HOANG, BO HAN and BA X. HOANG
    In Vivo September 2023, 37 (5) 2155-2160; DOI: https://doi.org/10.21873/invivo.13313
  • Open Access
    Therapeutic Efficacy of AFree Oral Spray on the Symptoms and Course of Moderate and Severe COVID-19 in the Field Hospital
    DUONG T. TRAN, TRUONG N. PHAM, NHUNG H.T. NGUYEN, HAU D. TRAN, HUY Q. HOANG, ANH K. NGUYEN, BO HAN and BA X. HOANG
    In Vivo July 2023, 37 (4) 1743-1750; DOI: https://doi.org/10.21873/invivo.13262
  • Open Access
    Letter to the Editor: RE: Reyes-Ruiz et al.: Encephalitis Associated With SARS-CoV-2 Infection in a Child With Chiari Malformation Type I. In Vivo 37(2): 933-939, 2023 – SARS-CoV-2-related Encephalitis Does Not Adequately Explain Oral Ulcers and Odynophagia
    JOSEF FINSTERER
    In Vivo July 2023, 37 (4) 1920-1921; DOI: https://doi.org/10.21873/invivo.13287
  • Open Access
    Efficacy of Tocilizumab in Severely Ill COVID-19 Patients With Rapid Respiratory Deterioration: A Single Center Experience During the Third Pandemic Wave in Greece
    VASILIKI RAPTI, MARIA-EFFROSYNI LIVANOU, ANASTASIOS KOLLIAS, TILEMACHOS KOUTOURATSAS, ORESTIS SAVRANAKIS, VISSARIA SAKKA, THOMAS NITSOTOLIS, ELENI KAKALOU, KALOMOIRA ATHANASIOU, KONSTANTINOS N. SYRIGOS and GARYFALLIA POULAKOU
    In Vivo May 2023, 37 (3) 1312-1317; DOI: https://doi.org/10.21873/invivo.13210
  • Open Access
    Encephalitis Associated With SARS-CoV-2 Infection in a Child With Chiari Malformation Type I
    JOSÉ MANUEL REYES-RUIZ, CLAUDIA MANRIQUE-CALVILLO, GUSTAVO MARTÍNEZ-MIER, ARTURO OSVALDO SERVIN-MONROY, GILRAED MOTA-GARCÍA, FLOR DE MARIA LUGO-MIRANDA, ENRIQUE VILLEGAS-DEL ANGEL, PAOLA ZARATE-SEGURA, FERNANDO BASTIDA-GONZALEZ and ROSA MARIA DEL ANGEL
    In Vivo March 2023, 37 (2) 933-939; DOI: https://doi.org/10.21873/invivo.13165
  • Open Access
    Prolonged SARS-CoV-2 Infection With Common Features in Two Patients Receiving Anti-CD20 Therapy
    AMALIA PAPANIKOLOPOULOU, VASILIS THIMIS, EIRINI ANTONOGIANNAKI, VASILIKI RAPTI, KONSTANTINOS TSIAKOS, GIANNIS KRALLIS, SOFIA NTOURAKI, GEORGIOS KOKKOTIS, EMMANOUIL PANAGIOTOU, VISSARIA SAKKA, ELENI KAKALOU, THOMAS NITSOTOLIS, GARYPHALLIA POULAKOU and KONSTANTINOS N. SYRIGOS
    In Vivo January 2023, 37 (1) 461-467; DOI: https://doi.org/10.21873/invivo.13100
  • Open Access
    Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens
    PATRICK MORHART, SVEN KEHL, WOLFGANG SCHUH, KATHARINA HERMES, STEFAN MELTENDORF, ANTJE NEUBERT, MICHAEL SCHNEIDER, MONIKA BRUNNER-WEINZIERL, HOLM SCHNEIDER and HOLGER LINGEL
    In Vivo January 2023, 37 (1) 70-78; DOI: https://doi.org/10.21873/invivo.13055
  • Open Access
    Biomarker Changes in Pediatric Patients With COVID-19: A Retrospective Study from a Single Center Database
    CRISTIAN NICOLAE SAVA, TEODORA-MARIA BODOG, LARISA ROXANA NIULAS, ALIN REMUS IUHAS, CRISTIAN PHILLIP MARINAU, NICOLETA NEGRUT, ANDREEA BIANCA BALMOS, BIANCA PASCA, NADINNE ALEXANDRA ROMAN and CARMEN DELIA NISTOR-CSEPPENTO
    In Vivo November 2022, 36 (6) 2813-2822; DOI: https://doi.org/10.21873/invivo.13019

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
In Vivo

© 2023 In Vivo

Powered by HighWire